Back to Market返回行情
RO
ROP.SW Roche Holding AG
SIXHealthcare$318.50-3.28%OpenMarket Cap: $253.53B
As of 2026-06-01 10:49
Valuation
P/E (TTM)
19.68
PEG
—
P/B
7.50
P/S
4.12
EV/EBITDA
12.34
DCF Value
—
FCF Yield
4.7%
Div Yield
3.1%
Margins & Returns
Gross Margin
73.5%
Operating Margin
28.9%
Net Margin
20.9%
ROE
41.2%
ROA
12.8%
ROIC
18.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $30.57B | 72.9% | $8.50B | $5.47B | $6.81 | — |
| Q2 2025 | $30.94B | 74.1% | $9.25B | $7.41B | $9.23 | — |
| Q4 2024 | $31.64B | 72.2% | $8.04B | $2.02B | $2.52 | — |
| Q2 2024 | $30.76B | 75.7% | $10.85B | $6.26B | $7.78 | — |
| Q4 2023 | $28.94B | 71.4% | $6.89B | $4.36B | $5.42 | — |
| Q2 2023 | $29.78B | 74.7% | $9.46B | $7.14B | $8.88 | — |
| Q4 2022 | $30.99B | 70.7% | $7.90B | $3.89B | $4.87 | — |
| Q2 2022 | $32.30B | 69.8% | $10.27B | $8.53B | $10.53 | — |
| Q4 2021 | $32.09B | 67.4% | $8.05B | $6.13B | $7.15 | — |
| Q2 2021 | $30.71B | 69.9% | $9.23B | $7.80B | $9.05 | — |
| Q4 2020 | $29.04B | 70.9% | $7.88B | $6.22B | $7.20 | — |
| Q2 2020 | $29.28B | 73.0% | $9.84B | $8.08B | $9.33 | — |